Results 181 to 190 of about 32,355 (207)
Some of the next articles are maybe not open access.

Perinatal 6-Hydroxydopamine Modeling of ADHD

2015
The neonatally 6-hydroxydopamine (n6-OHDA)-lesioned rat has been the standard for 40 years, as an animal model of attention-deficit hyperactivity disorder (ADHD). Rats so lesioned during postnatal ontogeny are characterized by ~99 % destruction of dopaminergic nerves in pars compacta substantia nigra, with comparable destruction of the nigrostriatal ...
Kostrzewa, John P.   +4 more
openaire   +3 more sources

l-DOPA administration enhances 6-hydroxydopamine generation

Brain Research, 2005
The therapeutic success of L-3,4-dihydroxyphenylalanine (L-DOPA) treatment in Parkinson's disease (PD) patients remains controversial as many patients become tolerant requiring higher dosage regimens. However, the increase in dosage regimens results in the patients experiencing intolerable side effects. This study sought to investigate whether dopamine
Himant, Maharaj   +4 more
openaire   +2 more sources

Behavioural effects of neonatal systemic 6-hydroxydopamine

Neuropharmacology, 1978
Abstract Rats were injected systemically (2 × 50 μg/g) with 6-hydroxydopamine either on the first, fifth or tenth day of life. Whereas brain dopamine was generally unaffected, norepinephrine assays during adult-hood showed age-dependent effects of the injections, with the greatest effect observed after injections on day 1.
M, Saari, B A, Pappas
openaire   +2 more sources

Dexmedetomidine Regulates 6-hydroxydopamine-Induced Microglial Polarization

Neurochemical Research, 2017
Microglia have undergone extensive characterization and have been shown to present distinct phenotypes, such as the M1 or M2 phenotypes, depending on their stimuli. As a highly specific neurotoxin, 6-hydroxydopamine (6-OHDA) can be used to further our understanding of the immune response in Parkinson's disease (PD).
Pei, Zhang   +4 more
openaire   +2 more sources

Iron protects astrocytes from 6-hydroxydopamine toxicity

Neuropharmacology, 2005
The role of iron in 6-hydroxydopamine (6-OHDA) toxicity towards astrocytes was investigated in vitro using rat primary astrocytes, rat astrocytoma cell line C6, and human astrocytoma cell line U251. The assessment of mitochondrial respiration or lactate dehydrogenase release has shown a dose-dependent decrease in the viability of astrocytes treated ...
Zogović, Nevena   +5 more
openaire   +4 more sources

Phosphorylation of p66shc mediates 6-hydroxydopamine cytotoxicity

Free Radical Research, 2010
6-Hydroxydopamine (6-OHDA) is a neurotoxin that has been widely used to generate Parkinson's disease (PD) models. Increased oxidative stress is suggested to play an important role in 6-OHDA-induced cell death. Given the lessened susceptibility to oxidative stress exhibited by mice lacking p66shc, this study investigated the role of p66shc in the ...
Tohru, Yamamori   +6 more
openaire   +2 more sources

Free Radical‐Generated Neurotoxicity of 6‐Hydroxydopamine

Journal of Neurochemistry, 1995
Abstract: Albino rats were lesioned bilaterally with 6‐hydroxydopamine (6‐OHDA) hydrochloride (4 µg/µl, dissolved in saline with 0.1% ascorbic acid) into the striatum, and 72 h after the injection, levels of lipid peroxidation, GSH, superoxide dismutase (SOD), glutathione peroxidase (GSH‐Px), lipid class, membrane fluidity, and intracellular calcium ...
R, Kumar, A K, Agarwal, P K, Seth
openaire   +2 more sources

Chemical Sympathectomy with 6-Hydroxydopamine

1970
The removal or destruction of an organ to elucidate its physiological role is one of the oldest and most commonly used methods in biological research. This principle has found extensive application in the investigation of the physiology and pharmacology of the sympathetic nervous system [Cannon and Rosenblueth, 1949; Trendelenburg, 1963 (1, 2)].
H. Thoenen, J. P. Tranzer, G. Häusler
openaire   +1 more source

6-Hydroxydopamine induces thymocyte apoptosis in mice

Journal of Neuroimmunology, 1996
6-Hydroxydopamine (6-OHDA) induces degeneration of noradrenergic nerves and has been shown to alter the immune responses. In this study, intraperitoneal administration of 6-OHDA induces mouse thymus atrophy. The lowest levels of thymus weight and cell number were reached at days 3 and 5 in mice receiving 6-OHDA treatment; they gradually recovered ...
C W, Tsao   +3 more
openaire   +2 more sources

Oxidation of 6-hydroxydopamine catalyzed by tyrosinase

International Journal of Biochemistry, 1993
1. The oxidation of 3,4-dihydroxyphenylethylamine (dopamine) by O2 catalyzed by tyrosinase yields 4-(2-aminoethyl)-1,2-benzoquinone, with its amino group protonated (o-dopaminequinone-H+), which evolves non-enzymatically through two branches or sequences of reactions, whose respective operations are determined by the pH of the medium. 2.
J N, Rodriguez-López   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy